Zurich Heart Center Presents Clinical Experience With ESVS® Mesh At International Society Of Minimally Invasive Cardiothoracic Surgeons (ISMICS) Annual Meeting

Manny Villafaña, Chairman and CEO of Kips Bay Medical Inc. (NASDAQ:KIPS) announced that Prof. Michele Genoni, MD, Chief of Cardiovascular Surgery of the Triemli Hospital, Zurich, Switzerland will be presenting his center’s early clinical experience with the eSVS ® Mesh device at the 14 th Annual meeting of the ISMICS in Los Angeles, CA. He will be presenting in the Late Breaking News session at 1:50 pm PT on Friday June 1, 2012.

ISMICS was formed to organize and centralize the various surgical centers concerned with patient outcomes, techniques, and progressive development of less invasive forms of heart surgery and is taking a leadership role in shaping the direction of less invasive cardiac surgery on a global basis.

About Kips Bay Medical

Kips Bay Medical, Inc., founded in 2007 and headquartered in Minneapolis, Minnesota, is a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, or eSVS MESH for use in coronary artery bypass grafting surgery. The eSVS MESH is a nitinol mesh sleeve that, when placed over a saphenous vein graft during CABG surgery, is designed to improve the structural characteristics and long-term performance of the saphenous vein graft. Additional information about Kips Bay Medical, Inc. can be found at www.KipsBayMedical.com.

Copyright Business Wire 2010

If you liked this article you might like

3 Stocks Moving The Health Services Industry Upward

3 Stocks Moving The Health Services Industry Upward

3 Stocks Under $10 Making Big Moves

3 Stocks Under $10 Making Big Moves

4 Health Care Stocks Under $10 to Watch

4 Health Care Stocks Under $10 to Watch

5 Worst IPOs of 2011

5 Worst IPOs of 2011

IPO Lessons From Pandora

IPO Lessons From Pandora